My key research interest within the Bahn lab is to develop functional cytomic models for biomarker elucidation and drug discovery in psychiatric disorders using primary patient samples exvivo and induced pluripotent stem (iPS) cells. For my undergraduate degree I studied Biological Sciences with specialization in Neurosciences at the University of Edinburgh (UK). I have over five years of experience in the biotech industry working on personalized medicine and drug discovery at Vivia Biotech (Spain) and Novasite Pharmaceuticals (San Diego, USA).
Sureyya Ozcan PhD
I am a bioanalytical chemist specialising in mass spectrometry with clinical, biological, nutritional and pharmacological applications. I hold a BSc degree (Gazi University, Turkey) and PhD degree in Chemistry (University of California, Davis, USA). My research interest is developing Mass Spectrometry based tools for the discovery of diagnostic and prognostic disease markers. I primarily use an `OMICS` approach; Glycomics, Glycoproteomics and Proteomics to unravel the complexity of biological systems. I am also interested in developing protocols for the characterization of glycans. glycoproteins and therapeutics.
I work part-time as a postdoctoral scientist at CCNR, where I analyse data arising from our research. The rest of my time is devoted to managing clinical research at our spin-out company, Psyomics. I work within Psyomics to coordinate our efforts with CCNR to investigate and develop technologies to better diagnose bipolar disorder and major depressive disorder. I recently completed a PhD in biotechnology at the CCNR, which looked at sex differences in psychiatric biomarkers. Prior to that, I graduate with a BSc in chemical engineering from the University of Alberta (Canada).
Jakub Tomasik PhD
My project is focused on novel treatment approaches for schizophrenia. I am particularly interested in improving response rates to current antipsychotic medications by applying biomarker strategies in the clinical decision making process as well as in the discovery of novel neuroleptic drugs in pre-clinical models and clinical trials. I have a strong background in biomarker discovery and statistical modelling from my PhD studies in Neuroscience under the supervision of Prof. Bahn at Cambridge University and the Erasmus Medical Centre in Rotterdam, my MSc studies in Biotechnology at Jagiellonian University in Krakow and my internship at the Max Planck Institute of Psychiatry in Munich.